24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
05/02/2014
Award for the T-Systems Data Center located in the Barcelona Synchrotron Park
27/01/2014
Companies from the Barcelona Synchrotron Park will have a privileged access to the ICMAB scientific equipments
20/01/2014
The Catalan Institute of Nanoscience and Nanotechnology opens its new building
14/01/2014
Barcelona, the 4th smartest city in Europe
03/01/2014
The Vall d’Hebron Institut de Recerca becomes a UAB-affiliated research institute
28/11/2013
Visit of a Moscow City Council delegation at Barcelona Synchrotron Park (BSP)